NDC 55154-3563-00 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-3563
- Requested NDC
- 55154-3563-00
- Package NDCs from labels
- 55154-3563-0, 55154-3563-00
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-3563-0 | Levothyroxine Sodium | 10 in 1 BAG | TABLET | 10 | 8 | |
| 55154-3563-0 | Levothyroxine Sodium | 1 in 1 BLISTER PACK | TABLET | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-3563 | LEVOTHYROXINE SODIUM TABLET [CARDINAL HEALTH 107, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20240906_31a31756-68aa-4e01-bbb1-9d181f8d9181.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | 8MDF5V39QO |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | 8MDF5V39QO |
| CVS Effervescent Antacid and Pain Reliever | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | CVS Pharmacy | 4ac63cf7-f064-30a1-e054-00144ff88e88 | 2026-05-11 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Vitamex USA, Corp | 5195cab5-bdda-2ddf-e063-6394a90ac9fe | 2026-05-11 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 50fe00b3-6610-1cac-e063-6294a90af8ac | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 5100c561-0028-a3c0-e063-6394a90addeb | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966220 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 510349d0-6397-7e2b-e063-6394a90a8a68 | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | TWIN MED LLC | 0f867f56-4bc0-4a85-b9d2-a16282b7c82b | 2026-05-01 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | f94a81e2-49cd-430a-acda-1a47d5c5b59b | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 892246 9J765S329G |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 4a2c8e57-d52d-409f-83d8-731b721bf613 | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 4caf9040-5507-45a4-8f42-231aa925ab8d | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 4f97d398-2118-0874-e063-6394a90a4ad1 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | f347d92a-7726-4165-bc3c-f5b37ec86f9f | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.